The U.S. Agency for International Development (USAID) has committed $2.3 million to procure 4.8 million doses of life-saving malaria tablets from Swiss Pharma (Swipha) in a landmark partnership that will expand access to essential medicines in Nigeria and West Africa. During her visit to Swipha’s facility in Lagos, USAID Mission Director to Nigeria, Melissa Jones, commented, “This achievement is a testament to the power of collaboration in improving healthcare in Nigeria. We are proud to have supported Swipha in reaching this milestone and look forward to continuing our partnership...